Dantao Peng

2.8k total citations
71 papers, 804 citations indexed

About

Dantao Peng is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Dantao Peng has authored 71 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 20 papers in Psychiatry and Mental health and 18 papers in Molecular Biology. Recurrent topics in Dantao Peng's work include Alzheimer's disease research and treatments (26 papers), Dementia and Cognitive Impairment Research (17 papers) and Advanced Neuroimaging Techniques and Applications (10 papers). Dantao Peng is often cited by papers focused on Alzheimer's disease research and treatments (26 papers), Dementia and Cognitive Impairment Research (17 papers) and Advanced Neuroimaging Techniques and Applications (10 papers). Dantao Peng collaborates with scholars based in China, United States and Canada. Dantao Peng's co-authors include Zhanjun Zhang, Wen Shao, Haiyan Zhu, Xiaoqian Niu, Xiaomin Wang, Yuye Wang, Xiaomin Wang, Xuejiao Ding, Dongfeng Wei and Rui Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and The Journals of Gerontology Series A.

In The Last Decade

Dantao Peng

69 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dantao Peng China 17 265 203 167 161 124 71 804
Yulei Deng China 20 386 1.5× 338 1.7× 207 1.2× 173 1.1× 54 0.4× 48 987
Antonietta Fava Italy 16 381 1.4× 147 0.7× 189 1.1× 152 0.9× 205 1.7× 26 988
Yi Xing China 18 212 0.8× 170 0.8× 189 1.1× 133 0.8× 106 0.9× 52 758
Robert Rusina Czechia 16 312 1.2× 204 1.0× 204 1.2× 207 1.3× 327 2.6× 71 938
Marwan Sabbagh United States 8 432 1.6× 218 1.1× 349 2.1× 154 1.0× 131 1.1× 13 927
Mami Takemoto Japan 18 254 1.0× 245 1.2× 124 0.7× 185 1.1× 267 2.2× 118 981
Luc Bracoud United States 11 410 1.5× 126 0.6× 128 0.8× 133 0.8× 137 1.1× 42 679
Michael Gejl Denmark 16 457 1.7× 275 1.4× 89 0.5× 169 1.0× 118 1.0× 25 1.2k
S. Engelborghs Belgium 16 375 1.4× 251 1.2× 254 1.5× 196 1.2× 223 1.8× 26 1.0k
Kenji Wada‐Isoe Japan 20 271 1.0× 349 1.7× 272 1.6× 151 0.9× 409 3.3× 44 1.2k

Countries citing papers authored by Dantao Peng

Since Specialization
Citations

This map shows the geographic impact of Dantao Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dantao Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dantao Peng more than expected).

Fields of papers citing papers by Dantao Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dantao Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dantao Peng. The network helps show where Dantao Peng may publish in the future.

Co-authorship network of co-authors of Dantao Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Dantao Peng. A scholar is included among the top collaborators of Dantao Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dantao Peng. Dantao Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jiong, Kristine Yaffe, Joseph R. Winer, et al.. (2025). Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's disease. Alzheimer s & Dementia. 21(2). e14495–e14495. 7 indexed citations
2.
Wang, Yu, Wen Shao, Zhi Zhou, et al.. (2024). Association between Alzheimer's disease pathologic products and age and a pathologic product-based diagnostic model for Alzheimer's disease. Frontiers in Aging Neuroscience. 16. 1513930–1513930.
3.
Lv, Shuang, et al.. (2024). Downregulation of Ripk1 and Nsf mediated by CRISPR-CasRx ameliorates stroke volume and neurological deficits after ischemia stroke in mice. Frontiers in Aging Neuroscience. 16. 1401038–1401038. 1 indexed citations
4.
Wang, Yuye, Yu Wang, Zhi Zhou, et al.. (2023). Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer’s disease: findings based on urine proteomics and machine learning. Alzheimer s Research & Therapy. 15(1). 191–191. 14 indexed citations
5.
Wang, Yuye, Yu Wang, Zhi Zhou, et al.. (2023). Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer’s disease. Frontiers in Aging Neuroscience. 15. 1273807–1273807. 7 indexed citations
6.
Zhang, Bin, et al.. (2023). Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease. Frontiers in Aging Neuroscience. 15. 1150510–1150510. 33 indexed citations
7.
Peng, Dantao, et al.. (2023). Research on digital tool in cognitive assessment: a bibliometric analysis. Frontiers in Psychiatry. 14. 1227261–1227261. 4 indexed citations
8.
Wang, Lei, et al.. (2023). Altered local and remote functional connectivity in mild Alzheimer’s disease patients with sleep disturbances. Frontiers in Aging Neuroscience. 15. 1269582–1269582. 4 indexed citations
9.
Zhang, Shujuan, Yiming Li, Dongfeng Wei, et al.. (2023). Prebiotics modulate the microbiota–gut–brain axis and ameliorate cognitive impairment in APP/PS1 mice. European Journal of Nutrition. 62(7). 2991–3007. 29 indexed citations
10.
Huang, Zhenguo, et al.. (2023). Evaluation of glymphatic system activity by diffusion tensor image analysis along the perivascular space (DTI-ALPS) in dementia patients. British Journal of Radiology. 96(1146). 20220315–20220315. 41 indexed citations
12.
Peng, Dantao, et al.. (2022). [Expert consensus on clinical application of Compound Congrong Yizhi Capsules in treatment of vascular dementia].. PubMed. 47(23). 6514–6519. 1 indexed citations
14.
Cui, Lei, Yeqiong Zhang, Wei Wang, et al.. (2020). Questioning the existence of monophasic neuromyelitis optica spectrum disorder by defining a novel long-term relapse-free form from a large Chinese population. Journal of Neurology. 267(4). 1197–1205. 16 indexed citations
15.
Zhang, Shujuan, Dongfeng Wei, Wei Liu, et al.. (2019). Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formation. Biomedicine & Pharmacotherapy. 121. 109682–109682. 21 indexed citations
16.
Wu, Hao, et al.. (2017). The role of butyrylcholinesterase in the pathogenesis of Alzheimer's disease. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Shao, Wen, Dantao Peng, & Xiaomin Wang. (2017). Genetics of Alzheimer’s disease: From pathogenesis to clinical usage. Journal of Clinical Neuroscience. 45. 1–8. 33 indexed citations
18.
Wei, Dongfeng, Chen‐Long Lv, Junying Zhang, et al.. (2015). The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study.. Europe PMC (PubMed Central). 8(5). 7507–16. 2 indexed citations
19.
Liang, Ying, Yaojing Chen, He Li, et al.. (2015). Disrupted Functional Connectivity Related to Differential Degeneration of the Cingulum Bundle in Mild Cognitive Impairment Patients. Current Alzheimer Research. 12(3). 255–265. 12 indexed citations
20.
Peng, Dantao, et al.. (2013). Hyperphosphorylation of Tau Protein in Hippocampus of Central Insulin-Resistant Rats is Associated with Cognitive Impairment. Cellular Physiology and Biochemistry. 32(5). 1417–1425. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026